Skip to main content
OpenTrials
Completed

NCT Number: NCT03301519

Genetics of Beta Cell Failure in Mexican Americans

This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Mexican American women with prior gestational diabetes and their first degree relatives and Mexican American women with prior normal glucose tolerance in pregnancy are studied with detailed phenotyping consisting of oral and intravenous glucose tolerance tests, body composition studies, diet and physical activity assessments, and circulating biomarkers potentially related to obesity, insulin resistance, pancreatic beta cell function, gestational diabetes and type 2 diabetes. Spouses of the gestational diabetic and control probands are studied with oral glucose tolerance tests. Offspring of the gestational and control probands have fasting glucose determinations. All participants provide DNA for genetics testing. A subset of the gestational diabetic probands and their first degree relatives return 3-5 years after baseline testing for repeat phenotyping.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Probands with Prior Gestational Diabetes Mellitus ("GDM PROBANDS")
  • Mexican American (parents and at least 3/4 four grandparents
  • age >18 years
  • GDM in singleton pregnancy in prior 5 years
  • impaired glucose levels or sum of five OGTT glucose values >625 mg/dl on 75 gram oral glucose tolerance test
  • Fasting plasma glucose <126 mg/dl
  • At least two adult siblings of cousin not known to have diabetes and available for phenotyping; .
  • Siblings and Cousins of GDM Probands
  • Full sibling or first cousin of GDM proband
  • Age >18 yrs
  • Fasting plasma glucose <126 mg/dl.
  • Parents, Uncles and Aunts of GDM Probands
  • Full blooded parent, uncle or aunt of GDM proband
  • Control Proband
  • Mexican American as defined for GDM probands
  • One glucose challenge test result <120 mg/dl at >24 weeks gestation
  • No diabetes in first degree relative
  • Frequency matched to GDM probands by distributions of age, BMI and parity.
  • Spouse of GDM or Control Proband
  • Spouse of GDM proband
  • Age >18
  • At least one child with proband able to provide DNA
  • Child of Proband
  • Child of GDM or control proband and spouse who provided DNA

Exclusion criteria

  • PROBANDS (GDM OR CONTROL):
  • Chronic medical illness or medication known to alter glucose/insulin metabolism
  • Current pregnancy or breastfeeding
  • Ilicit drug or alcohol abuse,
  • Inability or unwillingness to give informed consent.
  • SIBLINGS AND COUSINS OF PROBANDS:
  • Chronic medical illness or medication known to affect glucose/insulin metabolism
  • Current pregnancy or breastfeeding,
  • Ilicit drug or alcohol abuse
  • Inability or unwillingness to give informed consent.
  • PARENTS OF PROBANDS
  • Inability or unwillingness to give informed consent.
  • SPOUSE OF GDM or CONTROL PROBAND
  • Inability or unwillingness to give informed consent.
  • CHILD OF GDM or CONTROL PROBAND
  • Lack of parent consent or child assent.

Treatment and study plan

Primary outcomes

  1. Pancreatic Beta Cell Compensation for Insulin Resistance

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Disposition index from intravenous glucose tolerance test

Secondary outcomes

  1. Insulin Senstivity

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Si from computer modeled intravenous glucose tolerance test

  2. Acute Insulin Release

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Incremental area under insulin curve during first 10 minutes intravenous glucose tolerance test

  3. Glucose tolerance

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    normal, impaired or diabetic glucose level determined using American Diabetes Associate criteria applied to glucose levels from a 2-hour, 75 gram oral glucose tolerance test

  4. Diabetes type 2

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Fasting glucose >125 mg/dl and/or 2-hour glucose on 75 gram oral glucose tolerance test >199 mg/dl

  5. Dietary Intake

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Measured by semi-quantitative Harvard Food Frequency Questionnaire

  6. Physical Activity

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Measured by Multi-ethnic Cohort Physical Activity Questionnaire

  7. Body Fat

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Percent body fat measured by dual photon X-ray absorptiometry

  8. Circulating adipokine levels

    Time frame: Single time point for primary cohort, repeated 4.5 years later in subset

    Fasting levels of approximately 20 adipocytokines

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • Kaiser Permanente

Registry information

Important dates

Study start
2001
Primary completion
2013
Study completion
2013
First posted
Oct 4, 2017
Registry last updated
Nov 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.